[HTML][HTML] Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
CJ Aguiar, JA Rocha-Franco, PA Sousa… - Cell Communication and …, 2014 - Springer
Cell Communication and Signaling, 2014•Springer
Background Succinate is an intermediate of the citric acid cycle as well as an extracellular
circulating molecule, whose receptor, G protein-coupled receptor-91 (GPR91), was recently
identified and characterized in several tissues, including heart. Because some pathological
conditions such as ischemia increase succinate blood levels, we investigated the role of this
metabolite during a heart ischemic event, using human and rodent models. Results We
found that succinate causes cardiac hypertrophy in a GPR91 dependent manner. GPR91 …
circulating molecule, whose receptor, G protein-coupled receptor-91 (GPR91), was recently
identified and characterized in several tissues, including heart. Because some pathological
conditions such as ischemia increase succinate blood levels, we investigated the role of this
metabolite during a heart ischemic event, using human and rodent models. Results We
found that succinate causes cardiac hypertrophy in a GPR91 dependent manner. GPR91 …
Background
Succinate is an intermediate of the citric acid cycle as well as an extracellular circulating molecule, whose receptor, G protein-coupled receptor-91 (GPR91), was recently identified and characterized in several tissues, including heart. Because some pathological conditions such as ischemia increase succinate blood levels, we investigated the role of this metabolite during a heart ischemic event, using human and rodent models.
Results
We found that succinate causes cardiac hypertrophy in a GPR91 dependent manner. GPR91 activation triggers the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), the expression of calcium/calmodulin dependent protein kinase IIδ (CaMKIIδ) and the translocation of histone deacetylase 5 (HDAC5) into the cytoplasm, which are hypertrophic-signaling events. Furthermore, we found that serum levels of succinate are increased in patients with cardiac hypertrophy associated with acute and chronic ischemic diseases.
Conclusions
These results show for the first time that succinate plays an important role in cardiomyocyte hypertrophy through GPR91 activation, and extend our understanding of how ischemia can induce hypertrophic cardiomyopathy.
Springer